The firm also increased its target multiple to 28 times the next twelve months' (NTM) price-to-earnings (P/E), up from the previous multiple of 27 times. Despite the slight decrease in the price ...

Infosys Share Price: Infosys shares fell nearly 5% after its Q3 results showed an 11% YoY net profit growth, reaching Rs 6,806 crore, and revenue increasing 8% YoY to Rs 41,764 crore. Despite revising ...

Despite the positive outcomes, analysts highlighted concerns such as rising credit costs and slow deposit growth. Analysts maintained a 'Buy' or 'Outperform' rating, although revised target prices ...

The firm also increased its target multiple to 28 times the next twelve months’ (NTM) price-to-earnings (P/E), up from the previous multiple of 27 times. Despite the slight decrease in the price ...

The new price target reflects a 20.3 times multiple on the firm's forward 12-month earnings per share (EPS) estimate, which is a significant discount compared to Brown Forman's five-year average next ...

UnitedHealth Group 2024 revenue reached over $400 billion with adjusted EPS of $27.66. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site ...

which is a significant discount compared to Brown Forman's five-year average next twelve months (NTM) price-to-earnings (P/E) multiple of 33.3 times. The rationale behind the lowered price target ...

Meanwhile, SIS stock is trading at an attractive NTM (next 12 months) price-to-earnings multiple of 17.2, making it an excellent buy. Another small-cap stock that I am bullish on is WELL Health ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.